The First International Symposium on Pheochromocytoma ... inadequate methods to distinguish malignant from benign disease, and a lack of consensus on how to apply recent scientific and medical ...

At the age of 52 years, a man had begun to exhibit jaw tremor, decreased vocal volume, reduced facial expression and muscle pain, all of which suggested a diagnosis of Parkinson disease (PD).

and disease history, including previous surgical procedures (Figure 1). Medications known to provoke hypertensive crises in patients with pheochromocytoma include D2 dopamine receptor antagonists ...

The US Food and Drug Administration (FDA) will soon decide on whether to expand the label of MSD’s Welireg (belzutifan) to include its use for the treatment of the rare cancer pheochromocytoma ...

Welireg is intended for adults with VHL disease who need therapy for associated ... of adult and paediatric patients with advanced pheochromocytoma and paraganglioma. "EC conditionally approves ...

Conduction disorders (eg, Wolff-Parkinson-White). Monitor HR during therapy. Bronchospastic disease. Pheochromocytoma. Surgery. Diabetes. May mask signs and increase risk for hypoglycemia.

The panel of experts at the ISP felt strongly that localization of pheochromocytoma or paraganglioma ... tumors -- including recently discovered disease-causing genes (see below) -- there are ...